Diod PAO (Zavod ekologicheskoy tekhniki i ekopitaniya Diod PAO) is a Russia-based company primarily engaged in the pharmaceutical sector. Its main activities comprise the development and production of medicines based on natural raw materials, dietary supplements, medical cosmetic products, as well as medical equipment. Its products portfolio consists of such dietary supplements as iodine, selenium and calcium based vitamins, among others; pharmaceutical products; medical cosmetic products; and such equipment as silver water purifier and light therapy apparatus, among others. In addition, it owns a medical center Mir ekologii, which provides healthcare services. The Company operates through several subsidiaries and affiliated companies.
Ford US Equity Research covers more than 4,000 stocks using a proprietary quantitative model that evaluates a company’s earnings strength, its relative valuation and recent price movement. Ford’s five recommendation ratings include strong buy, buy, hold, sell, strong sell. For all stocks in our coverage universe, ratings are generated each week and reflect the fundamental and price data as of the last trading day of the week.
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.